title: Dissecting intensive treatment as risk factor for inhibitor development in haemophilia.
authors.affiliation: Department of Pediatric hematology, Emma Children's hospital, Academic Medical Center, Amsterdam, the Netherlands.
authors.forename: C L
authors.initials: CL
authors.lastname: Eckhardt
authors.affiliation: Department of Pediatric hematology, Emma Children's hospital, Academic Medical Center, Amsterdam, the Netherlands.
authors.forename: A S
authors.initials: AS
authors.lastname: van Velzen
authors.affiliation: Department of Pediatric hematology, Emma Children's hospital, Academic Medical Center, Amsterdam, the Netherlands.
authors.forename: C J
authors.initials: CJ
authors.lastname: Fijnvandraat
authors.affiliation: Jon J. van Rood Center for Clinical Transfusion Research, Sanquin Research and Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands.
authors.forename: J G
authors.initials: JG
authors.lastname: van der Bom
mesh_terms: D057134:Antibodies, Neutralizing / Q000097:blood*; D002986:Clinical Trials as Topic; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D057134:Antibodies, Neutralizing; D005169:Factor VIII